開示資料
2019/09/20
Agreement on Joint Research into SB623 for Indication of Retinal Disease2019/09/19
- SanBio Granted Regenerative Medicine Advanced Therapy Designation from the U.S. FDA for SB623 for the Treatment of Traumatic Brain Injury
2019/09/19
- 慢性期外傷性脳損傷を対象にした再生細胞薬SB623が米国食品医薬品局の「RMAT」の対象品目に指定
2019/09/13
- 2020年１月期第２四半期累計期間の資金調達の総括について
2019/09/13
- Summary of Procurement of Funds in the First Half of the Fiscal Year Ending January 31, 2020
2019/09/13
- Notice Concerning Difference Between Consolidated Financial Forecasts and Actual Results for the First Half of the Fiscal Year Ending January 31, 2020
2019/09/13
- 営業外費用（為替差損）の計上に関するお知らせ
2019/09/13
- SB623外傷性脳損傷を対象にした第２相試験（STEMTRA試験）結果が2019 World Federation of Neurosurgical Societies Special World Congressにて発表について
2019/09/13
- Notice of Posting of Non-Operating Expenses (Foreign Exchange Losses)
2019/09/13
- SanBio announced the results of the Phase 2 STEMTRA trial at 2019 World Federation of Neurosurgical Societies Special World Congress
2019/09/13
- Consolidated Financial Results for the Six Months Ended July 31, 2019 [Japanese GAAP]
2019/08/30
- SanBio Announced the results of the Phase 2 STEMTRA trial of SB623 was presented at the Military Health System Research Symposium 2019
2019/08/30
- SB623外傷性脳損傷を対象にした第２相試験（STEMTRA試験）結果がMilitary Health System Research Symposium 2019にて発表について
2019/08/16
- [Delayed]Basic Agreement for Commercial Distribution with Suzuken Co., Ltd. and Start of Development Related to Patient Support System
2019/08/06
- [Delayed]Announcement on Receiving Japanese Marketing License for Regenerative Medicine Products
2019/08/05
- 「再生医療等製品製造販売業許可」取得に関するお知らせ
2019/08/05
- 株式会社スズケンと再生細胞薬の流通（商流）に関する基本契約締結及び患者サポートシステムに関する共同開発開始のお知らせ
2019/07/30
- Determination of Terms and Conditions of Stock Options (Share Acquisition Rights)
2019/07/16
- Determination of Terms and Conditions of Stock Options (Share Acquisition Rights)
2019/07/12
- Announcement on Granting Stock Options (Share Acquisition Rights)
2019/07/10
- コーポレート・ガバナンスに関する報告書 2019/07/10
2019/06/28
- Announcement on Granting Stock Options (Share Acquisition Rights)
2019/06/14
- Notice of Posting of Non-Operating Income (Foreign Exchange Gains)
2019/06/14
- Consolidated Financial Results for the Three Months Ended April 30, 2019 [Japanese GAAP]
2019/06/14
- 営業外収益（為替差益）計上に関するお知らせ